Seed Health is headed to Sprouts.
Seed Health, known for its microbiome solutions, is now available in all 450 Sprouts doors across 24 states with its DS-01 Daily Synbiotic and DS-01 14 Day Gut Reset. Seed Health is also available at Target, where it is the number-one digestive health probiotic, and Erewhon. This retail news follows the appointment of Cathrin Bowtell, who previously was chief commercial officer and then president, as chief executive officer in April. Cofounders Ara Katz and Raja Dhir previously held the position.
Sources close to the brand confirmed that Seed has exceeded $200 million in revenue. Additionally, the brand has grown its revenue by 500 percent over the last three years.
According to Bowtell, the Sprouts expansion is the next step in the brand’s accessibility story, as it has gone from a primarily direct-to-consumer membership business to an omnichannel brand since its 2015 launch. According to Bowtell, each channel expansion has provided “pure incrementality” for the company.
“It’s a milestone for us. If you think about the omnichannel strategy that we’ve been incubating over the last year and a half, we actually have our retail roots in natural grocery,” she said, noting the brand launched at Erewhon in 2021.
Like Erewhon, Sprouts is a particular fit for the brand’s offering and target consumer.
“It’s a wonderful fit from a brand standpoint,” said Bowtell. “It’s fast-growing in the world of probiotics, but it’s also attracting a consumer who’s deeply health focused and accessibility focused.”
So far, Seed’s retail strategy has been crucial to better serve existing customers and reaching new ones, per search and performance data.
“When we launched on Amazon last year, we launched into that channel with about 30,000 searches a month for our product name without being on the platform. When we launched into Target in September, we quickly became one of the top 10 revenue producing stock keeping units in that set,” said Bowtell.
She predicts they will see a similar outcome now at Sprouts.
“We will, of course, find consumers at Sprouts that are brand aware and that are attracted to our packaging and our display, but our hope is also that us launching there provides an opportunity for consumers who are non-brand aware to discover us for the first time and try us for the first time,” said Bowtell. “We’ve seen the same thing happen across Target and Amazon.”
To date, more than a million consumers have used the brand’s innovations, which also include the VS-01 Vaginal Synbiotic, a microbiome-supporting suppository.
Seed’s entry into Sprouts is one piece of Bowtell’s overall vision for the brand, as she recently stepped into the role of CEO.
“This leadership transition has been planned for some time. I’ve been on board for over two and a half years, and have been incubating and leading the omnichannel strategy since that time,” she said. “What’s nice about this transition is there isn’t a big business strategy change. If anything, this transition helps us accelerate moving into that scale and that impact of the strategy that Ara, Raja and I all incubated together.”
Over the years Seed has continuously experienced growth thanks in part to its clinically backed formulas, which are often recommended by physicians ultimately adding another discovery outlet for consumers, and to the ongoing conversation around gut health, which experts say isn’t going anywhere.
“Gut health is connected to most biological systems in the human body, and via gut health, the consumer actually has so much agency power to impact their own health,” said Bowtell. “The focus on gut health is correlated to consumers wanting agency over their own whole body, holistic health and they want it without other types of interventions.”
While the gut health conversation has remained constant over the past several years, the digestive issues associated with GLP-1s have caused an even greater focus on the category recently.
As Bowtell looks to the future, she recognizes the challenges in the market, including possible economic downturn, but Seed’s success in recent months has shown that the business is resilient.
“Investments in people’s health are incredibly important to the customers that we sell our products to,” she said. “We continue to think about lots of different ways of making our products as accessible as possible. The Gut Reset product that we’re also launching at Sprouts is a nice example of a way that Seed aims to make our products accessible, giving lots of different ways of getting started at a range of price points.”
Additionally, McKinsey’s latest Future of Wellness Report for 2025 showed that wellness is staying relatively resilient, as consumers were unlikely to find it to be a discretionary category. That being said, Bowtell also said given the challenges in the market, Seed’s commitment to science with peer-reviewed clinical research will be more important than ever.
“Consumers are deeply educated today, and so the products that are going to resonate are going to be products that are highly efficacious,” she said, noting that there are new products on the horizon, though the company’s offering will remain highly curated.
“Everything that Seed will put into the market will have to meet the same threshold of the products we have in market today, which is at the forefront of efficacy, at the forefront of clinical superiority, and always with a very unique microbiome angle to health.”
